Trial NCT03023527

View at ClinicalTrials.gov 
Org. Study IDs: GEM-NIVOPOMDEX

Last trial update was posted on 2018-05-23

MeSH Interventions

Dexamethasone Elotuzumab Nivolumab Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Safety

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID